InvestorsHub Logo
Followers 54
Posts 4438
Boards Moderated 0
Alias Born 08/21/2015

Re: Darkoo post# 20528

Monday, 04/24/2017 12:33:23 PM

Monday, April 24, 2017 12:33:23 PM

Post# of 73508
Howard Phillips required Otiko to sign an Addendum to their NON-EXCLUSIVE Patent License Agreement in January 2017. It is attached to the recent Annual Report with Disclosures as an Exhibit.

The relevant excerpts are below:





Otiko signed this Addendum! It specifically states Otiko Products will have the same ingredients as Diabecline.

Otiko advertised Diabecline as their Lead Product on their website in February 2017. This is why I researched the website history using the Internet Archive tool Wayback Machine. I placed a table with the dates and "Lead Product" in the iBox. Anyone can perform the same search and find the same results. I checked the WB yesterday and no further screen captures have occurred since February 2017.

As for the different Codes. Viabecline has two extra ingredients. The Viabecline product info hasn't been updated on Daily Med since last year.

Wrong, they have two separate NDC Codes
DIABECLINE NDC Code(s): 43074-112-11
VIABECLINE NDC Code(s): 69006-002-00.